We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CTSO market cap is 71.38M. The company's latest EPS is USD -0.3309 and P/E is -3.41.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 9.79M | 9.9M | 9.39M | 6.52M | 8.73M |
| Operating Income | -4.93M | -3.42M | -4.4M | -6.37M | -3.89M |
| Net Income | -6.36M | -4.14M | -2.33M | -7.88M | -1.48M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 41.01M | 43.17M | 34.69M | 36.35M | 35.6M |
| Operating Income | -10.37M | -22.74M | -31.52M | -31.21M | -16.79M |
| Net Income | -7.84M | -24.56M | -32.81M | -28.51M | -20.72M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 47.07M | 53.43M | 47.8M | 47.37M | 50.78M |
| Total Liabilities | 28.14M | 36.69M | 34.81M | 36.27M | 36.24M |
| Total Equity | 18.93M | 16.74M | 13M | 11.11M | 14.54M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 89.95M | 89.52M | 63.23M | 53.26M | 47.37M |
| Total Liabilities | 10.74M | 26.94M | 27.86M | 29.99M | 36.27M |
| Total Equity | 79.22M | 62.58M | 35.38M | 23.28M | 11.11M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.83M | -9.63M | -12.09M | -14.43M | -3.47M |
| Investing | -127k | -246k | -545k | -669k | -47k |
| Financing | -572k | 9.26M | 9.16M | 9.33M | 6.83M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.61M | -14.01M | -28.23M | -21.66M | -14.43M |
| Investing | -1.68M | -4.28M | -6.46M | -936k | -669k |
| Financing | 66.35M | 715k | 4.96M | 14.47M | 9.33M |
| Market Cap | 71.38M |
| Price to Earnings Ratio | -3.41 |
| Price to Sales Ratio | 1.99 |
| Price to Cash Ratio | 21.56 |
| Price to Book Ratio | 6.37 |
| Dividend Yield | - |
| Shares Outstanding | 62.61M |
| Average Volume (1 week) | 109.58k |
| Average Volume (1 Month) | 142.88k |
| 52 Week Change | 15.15% |
| 52 Week High | 1.61 |
| 52 Week Low | 0.7101 |
| Spread (Intraday) | 0.86 (51.81%) |
| Company Name | CytoSorbents Corporation |
| Address |
874 walker rd ste c dover, delaware 19904 |
| Website | https://www.cytosorbents.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
